Scientists test eczema drug delivery in healthy volunteers
NCT ID NCT06268860
Summary
This study aimed to see if a potential eczema medication, rocatinlimab, is absorbed the same way by the body when given from a traditional glass vial versus a newer, ready-to-use prefilled syringe. It involved 240 healthy adults who received a single injection. The main goal was to compare drug levels in the blood between the two delivery methods to ensure they work equally well.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Fortrea Clinical Research Unit - Dallas
Dallas, Texas, 75247-4903, United States
-
Fortrea Clinical Research Unit - Daytona Beach
Daytona Beach, Florida, 32117-5116, United States
-
Fortrea Clinical Research Unit Inc. - Madison
Madison, Wisconsin, 53704-2526, United States
-
Fortrea Clinical Research Unit Limited - Leeds
Leeds, LDS, LS2 9LH, United Kingdom
Conditions
Explore the condition pages connected to this study.